tiprankstipranks
ABIONYX Pharma SA (FR:ABNX)
:ABNX
France Market
ABNX
ABIONYX Pharma SA
RESEARCH TOOLSreports
Want to see FR:ABNX full AI Analyst Report?

ABIONYX Pharma SA (ABNX) Ratios

5 Followers

ABIONYX Pharma SA Ratios

FR:ABNX's free cash flow for Q4 2025 was €0.10. For the 2025 fiscal year, FR:ABNX's free cash flow was decreased by € and operating cash flow was €-2.01. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.06 1.06 1.58 1.75 1.49
Quick Ratio
 1.01 1.01 1.52 1.70 1.46
Cash Ratio
 0.68 0.68 0.87 1.05 0.79
Solvency Ratio
 -0.58 -0.58 -0.65 -0.53 -0.47
Operating Cash Flow Ratio
 -0.57 -0.57 -0.97 -0.94 -0.66
Short-Term Operating Cash Flow Coverage
 -3.71 -3.70 -4.27 -7.31 -6.84
Net Current Asset Value
€ -3.14M€ -3.14M€ -167.00K€ -26.00K€ -1.08M
Leverage Ratios
Debt-to-Assets Ratio
 0.30 0.30 0.23 0.23 0.25
Debt-to-Equity Ratio
 0.89 0.89 0.42 0.43 0.56
Debt-to-Capital Ratio
 0.47 0.47 0.29 0.30 0.36
Long-Term Debt-to-Capital Ratio
 0.32 0.32 0.08 0.12 0.16
Financial Leverage Ratio
 3.02 3.02 1.81 1.87 2.21
Debt Service Coverage Ratio
 -5.39 -5.06 -4.27 -9.23 -3.49
Interest Coverage Ratio
 -31.27 -31.27 -91.34 -179.58 -17.12
Debt to Market Cap
 0.02 0.02 0.04 0.04 0.04
Interest Debt Per Share
 0.11 0.11 0.09 0.12 0.15
Net Debt to EBITDA
 -0.05 -0.05 0.03 0.15 <0.01
Profitability Margins
Gross Profit Margin
10.26%9.25%18.35%13.32%12.11%
EBIT Margin
-153.91%-153.95%-117.52%-100.95%-78.92%
EBITDA Margin
-140.35%-140.39%-107.13%-104.40%-76.35%
Operating Profit Margin
-153.91%-153.95%-121.13%-73.53%-78.24%
Pretax Profit Margin
-153.49%-153.53%-118.85%-75.82%-80.08%
Net Profit Margin
-136.42%-136.60%-95.65%-75.82%-80.08%
Continuous Operations Profit Margin
-136.42%-136.60%-95.65%-75.82%-80.08%
Net Income Per EBT
88.87%88.97%80.48%100.00%100.00%
EBT Per EBIT
99.73%99.73%98.12%103.11%102.36%
Return on Assets (ROA)
-43.10%-43.14%-32.71%-23.72%-26.58%
Return on Equity (ROE)
-114.60%-130.25%-59.27%-44.41%-58.67%
Return on Capital Employed (ROCE)
-81.22%-81.22%-57.18%-31.28%-38.30%
Return on Invested Capital (ROIC)
-69.47%-65.53%-41.03%-29.10%-23.16%
Return on Tangible Assets
-74.71%-74.79%-55.03%-37.52%-40.56%
Earnings Yield
-4.27%-4.12%-10.97%-9.29%-8.73%
Efficiency Ratios
Receivables Turnover
 2.56 2.56 2.00 1.86 4.05
Payables Turnover
 2.40 2.42 2.27 2.79 2.49
Inventory Turnover
 14.30 14.46 17.54 18.20 31.40
Fixed Asset Turnover
 2.26 2.26 2.32 2.09 2.05
Asset Turnover
 0.32 0.32 0.34 0.31 0.33
Working Capital Turnover Ratio
 4.34 3.31 1.80 1.71 1.20
Cash Conversion Cycle
 15.74 17.15 42.22 85.73 -44.76
Days of Sales Outstanding
 142.44 142.48 182.10 196.27 90.14
Days of Inventory Outstanding
 25.52 25.24 20.81 20.06 11.62
Days of Payables Outstanding
 152.23 150.57 160.70 130.59 146.52
Operating Cycle
 167.96 167.72 202.92 216.32 101.76
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.08 -0.08 -0.11 -0.13 -0.12
Free Cash Flow Per Share
 -0.08 -0.09 -0.11 -0.13 -0.13
CapEx Per Share
 <0.01 <0.01 0.00 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.03 1.08 1.00 1.04 1.05
Dividend Paid and CapEx Coverage Ratio
 -12.14 -12.12 0.00 -28.45 -19.19
Capital Expenditure Coverage Ratio
 -12.14 -12.12 0.00 -28.45 -19.19
Operating Cash Flow Coverage Ratio
 -0.77 -0.77 -1.16 -1.09 -0.84
Operating Cash Flow to Sales Ratio
 -0.72 -0.72 -0.78 -0.80 -0.64
Free Cash Flow Yield
-2.38%-2.36%-8.98%-10.11%-7.34%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -23.46 -24.25 -9.11 -10.76 -11.45
Price-to-Sales (P/S) Ratio
 31.23 33.12 8.72 8.16 9.17
Price-to-Book (P/B) Ratio
 30.53 31.58 5.40 4.78 6.72
Price-to-Free Cash Flow (P/FCF) Ratio
 -42.07 -42.38 -11.14 -9.89 -13.63
Price-to-Operating Cash Flow Ratio
 -44.29 -45.88 -11.14 -10.24 -14.34
Price-to-Earnings Growth (PEG) Ratio
 1.53 -1.05 -1.09 0.54 0.33
Price-to-Fair Value
 30.53 31.58 5.40 4.78 6.72
Enterprise Value Multiple
 -22.30 -23.64 -8.11 -7.67 -12.00
Enterprise Value
 126.86M 134.86M 39.96M 37.15M 48.13M
EV to EBITDA
 -22.24 -23.64 -8.11 -7.67 -12.00
EV to Sales
 31.22 33.19 8.69 8.01 9.16
EV to Free Cash Flow
 -42.05 -42.47 -11.10 -9.70 -13.62
EV to Operating Cash Flow
 -43.19 -45.98 -11.10 -10.05 -14.33
Tangible Book Value Per Share
 -0.03 -0.03 0.06 0.08 0.06
Shareholders’ Equity Per Share
 0.12 0.12 0.22 0.27 0.26
Tax and Other Ratios
Effective Tax Rate
 0.06 0.11 0.20 0.00 0.35
Revenue Per Share
 0.11 0.11 0.14 0.16 0.19
Net Income Per Share
 -0.15 -0.16 -0.13 -0.12 -0.15
Tax Burden
 0.89 0.89 0.80 1.00 1.00
Interest Burden
 1.00 1.00 1.01 0.75 1.01
Research & Development to Revenue
 0.37 0.37 0.65 0.63 0.49
SG&A to Revenue
 1.13 1.13 0.28 0.24 0.23
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 <0.01 0.10
Income Quality
 0.53 0.53 0.82 1.05 0.80
Currency in EUR